Endocrine Management of Prostatic Cancer / / H. Klosterhalfen.

Saved in:
Bibliographic Details
Superior document:Title is part of eBook package: De Gruyter DGBA Medicine and Life Sciences - <1990
HerausgeberIn:
:
Place / Publishing House:Berlin ;, Boston : : De Gruyter, , [2019]
©1988
Year of Publication:2019
Edition:Reprint 2019
Language:German
Series:New Developments in Biosciences ; 4
Online Access:
Physical Description:1 online resource (137 p.) :; Num. figs.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Other title:Frontmatter --
Contents --
I. Mechanism of hormonal action at cellular level and biochemistry --
Mechanism and effects of androgen withdrawal therapies /
Target-cell response to androgen withdrawal /
Effects of chronic treatment with an LH-RH agonist on human testis tissue /
Animal models for prostate cancer /
The significance of the nude mice model for studies on human prostatic carcinoma /
II. Etiology and experimental basis of therapy --
Etiology and natural history of early prostatic cancer /
Pharmacological basis of androgen deprivation by various antiandrogens and their combination with LH-RH agonists /
III. Clinics --
Evaluation of different endocrine approaches in the treatment of prostatic carcinoma /
Rationale of total androgen blockade by cyproterone acetate /
Clinical experience with Androcur® in the treatment of prostatic cancer /
Prostate cancer treatment: tolerance of different endocrine regimens /
Result of long-term treatment with cyproterone acetate (CPA) in advanced prostatic cancer patients /
Results and experience with the androgen ablation therapy: current trends in the USA /
Long-term results of an LH-RH agonist monotherapy in patients with carcinoma of the prostate and reflections on the so-called total androgen blockade with pre-medicated cyproterone acetate /
List of first-mentioned contributors
Format:Mode of access: Internet via World Wide Web.
ISBN:9783110853674
9783110637861
DOI:10.1515/9783110853674
Access:restricted access
Hierarchical level:Monograph
Statement of Responsibility: H. Klosterhalfen.